Killer Cells, more formally known as cytotoxic T lymphocytes (CTLs) or natural killer (NK) cells, are crucial components of the immune system, playing a central role in the body's defense against infected or abnormal cells. Cytotoxic T lymphocytes are a type of white blood cell that specifically targets and eliminates cells infected by viruses or those displaying abnormal proteins, such as cancer cells. These cells recognize antigens on the surface of target cells and release cytotoxic granules containing perforin and granzymes, inducing apoptosis or cell death. Natural killer cells, another subset of killer cells, possess innate cytotoxic capabilities, responding rapidly to infected or stressed cells without prior sensitization. Killer cells are instrumental in immune surveillance, patrolling the body to identify and eliminate threats. They contribute to the balance between immune response and self-tolerance, preventing the development of autoimmune conditions. Dysregulation of killer cell activity can have implications for various diseases, including viral infections, cancer, and autoimmune disorders. Immunotherapies harnessing the power of killer cells, such as adoptive cell transfer and checkpoint inhibitors, represent innovative approaches in cancer treatment. Understanding the intricate functions of killer cells is essential for advancing immunological research and developing targeted therapeutic strategies to combat a range of diseases.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States